Adaptive Biotechnologies Corp
ADPT
71 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 14 12:55 AM | Sharon BenzenoChief Commercial Ofc Imm Med | Sale | 63,103 | $13.17 | $831.1K | 272,751(D) | View → |
| Mar 11, 2026 | Mar 14 12:52 AM | Kyle PiskelChief Financial Officer | Sale | 18,672 | $13.17 | $245.9K | 259,840(D) | View → |
| Mar 11, 2026 | Mar 14 12:49 AM | Harlan S RobinsChief Scientific Officer | Sale | 470,266 | $13.17 | $6.2M | 1,522,058(D) | View → |
| Mar 11, 2026 | Mar 14 12:45 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 470,167 | $13.17 | $6.2M | 2,301,113(D) | View → |
| Mar 11, 2026 | Mar 11 8:42 PM | FRANCIS LO | Proposed Sale | 30,593 | $14.52 | $444.2K | — | View → |
| Mar 11, 2026 | Mar 11 8:21 PM | MICHELLE GRIFFIN | Proposed Sale | 15,394 | $13.91 | $214.1K | — | View → |
| Mar 10, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 19,460 | $14.68 | $285.7K | 643,471(D) | View → |
| Mar 9, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $14.79 | $457.6K | 647,809(D) | View → |
| Mar 6, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $15.14 | $468.4K | 652,147(D) | View → |
| Mar 5, 2026 | Mar 10 11:53 PM | LO FRANCIS | Proposed Sale | 38,074 | $16.44 | $625.9K | — | View → |
| Mar 5, 2026 | Mar 10 12:29 AM | Francis LOChief People Officer | Sale | 38,074 | $15.09 | $574.5K | 321,967(D) | View → |
| Mar 3, 2026 | Mar 6 1:05 AM | Michelle Renee GriffinDirector | Sale | 48,044 | $15.30 | $735.1K | 15,394(D) | View → |
| Mar 5, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $16.00 | $495.1K | 575,235(D) | View → |
| Mar 4, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $16.60 | $513.6K | 579,573(D) | View → |
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $15.67 | $484.8K | 583,911(D) | View → |
| Mar 3, 2026 | Mar 5 12:58 AM | Harlan S RobinsChief Scientific Officer | Sale | 14,233 | $16.52 | $235.1K | 1,155,291(D) | View → |
| Mar 2, 2026 | Mar 5 12:58 AM | Harlan S RobinsChief Scientific Officer | Sale | 10,000 | $15.72 | $157.2K | 1,169,524(D) | View → |
| Mar 3, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 53,083 | $15.52 | $823.8K | 1,934,247(D) | View → |
| Mar 2, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 289,024 | $15.82 | $4.6M | 1,987,330(D) | View → |
| Feb 27, 2026 | Mar 4 12:51 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 182,891 | $15.99 | $2.9M | 2,276,354(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 15,122 | $12.14 | 403,539(D) | View → |
| Mar 9, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 403,939(D) | View → |
| Mar 6, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 415,820(D) | View → |
| Mar 3, 2026 | Mar 6 1:05 AM | Michelle Renee GriffinDirector | Option Exercise | 48,044 | $3.99 | 0(D) | View → |
| Mar 5, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 427,701(D) | View → |
| Mar 4, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 439,582(D) | View → |
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 451,463(D) | View → |
| Feb 4, 2026 | Feb 7 12:30 AM | Kyle PiskelChief Financial Officer | Option Exercise | 2,145 | $12.14 | 2,146(D) | View → |
← Previous
Page 4 of 4